Hypolipidemic activity and mechanisms of the total phenylpropanoid glycosides from Ligustrum robustum (Roxb.) Blume by AMPK-SREBP-1c pathway in hamsters fed a high-fat diet

Phytotherapy Research : PTR
Runmei YangNannan Gao

Abstract

The aim of this study was to evaluate the hypolipidemic effect and mechanisms of total phenylpropanoid glycosides extracted from Ligustrum robustum (Roxb.) Blume (LRTPG) in hamsters fed a high-fat diet and to discover bioactive components in HepG2 cell model induced by oleic acid. LRTPG of high (1.2 g/kg), medium (0.6 g/kg), and low (0.3 g/kg) doses was administrated daily for 21 consecutive days in hamsters. We found that in hamsters fed a high-fat diet, LRTPG effectively reduced the concentrations of plasma triglycerides (TG), free fatty acid, total cholesterol, low-density lipoprotein cholesterol, and hepatic TG and total cholesterol. And the compounds acteoside, ligupurpuroside A, ligupurpuroside C, and ligupurpuroside D significantly inhibited lipid accumulation in HepG2 cell at the concentration of 50 μmol/L. Mechanism research demonstrated that LRTPG increased the levels of phospho-AMP-activated protein kinase and phospho-sterol regulatory element binding protein-1c in liver, further to suppress the downstream lipogenic genes as stearoyl-CoA desaturase 1, glycerol-3-phosphate acyltransferase, 1-acylglycerol-3-phosphate O-acyltransferase 2, and diacylglycerol acyltransferase 2. In addition, LRTPG increased the hydrolysis ...Continue Reading

References

Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·S CasesR V Farese
Nov 28, 2002·Journal of Lipid Research·Martin MerkelIra J Goldberg
Jun 28, 2003·Journal of Natural Products·Zhen-Dan HeHan-Dong Sun
Jan 30, 2004·Biochemical Society Transactions·G F GibbonsA-M Hebbachi
Jun 24, 2005·European Heart Journal·Christie BallantyneJames Shepherd
Apr 2, 2009·American Journal of Physiology. Endocrinology and Metabolism·Kazuharu Takeuchi, Karen Reue
Jul 9, 2009·Physiological Reviews·Gregory R Steinberg, Bruce E Kemp
Sep 22, 2011·BMC Evolutionary Biology·Andreia C Turchetto-ZoletRogerio Margis
Apr 15, 2014·Clinical Pharmacology and Therapeutics·S ZoungasA M Tonkin
Oct 30, 2016·British Journal of Pharmacology·Antonello Santini, Ettore Novellino
Jan 31, 2017·Nature Reviews. Endocrinology·Paola M Hunter, Robert A Hegele

❮ Previous
Next ❯

Citations

Jan 16, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ali Mohammad Pourbagher-ShahriSaeed Samargahndian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.